Ann: Appendix 4C - 31 December 2019, page-6

IP position continues to move forwardAn important component of Bio-Gene’s value proposition is its Intellectual Property. As noted previously the Company submitted two additional patent applications in 2018 covering two unique inventions as part of our strategy to provide added protection to our technology and therefore enhanced value to our potential customers. As part of the global patent application process the Company has now entered the specific country by country patent examination phase.Patent examination is a consultative and iterative process which involves questions being raised by a patent examiner which are to be rebutted by the applicant. Prior to entry into the current country by country phase, the World Intellectual Property Organisation (WIPO) conducts a search to give applicants guidance of potential prior art they may not be aware of. As WIPO searches are not binding on a specific country, the opinions they provide cannot be taken as a guide of the likelihood of ultimate patentability on a country by country basis. In the case of our two pending patent applications, the WIPO search did not reveal anything the Company and our attorneys were not previously aware of and the Company remains confident that granted patent claims will be issued in due course, which will extend our patent monopoly to 2038.